- Accession Number
Organic compounds containing two acyl groups bound to NITROGEN.
Drug Drug Description Lenalidomide A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. Pantothenic acid A vitamin B5 found in various nutritional supplements. Pomalidomide A thalidomide analogue used in combination with dexamethasone to treat patients with multiple myeloma. Chlorthalidone A diuretic used to treat hypertension or edema caused by heart failure, renal failure, hepatic cirrhosis, estrogen therapy, and other conditions. Ethosuximide An anticonvulsant used to treat petit mal seizures. Phensuximide For the treatment of epilepsy. 1-Ethyl-Pyrrolidine-2,5-Dione Not Available Bisindolylmaleimide VIII Not Available N-Ethylmaleimide A sulfhydryl reagent that is widely used in experimental biochemical studies. [PubChem] Bisindolylmaleimide I Not Available Bis(N-maleimidomethyl)ether Not Available Methsuximide A succinimide anticonvulsant that increases the seizure threshold. Primarily used for childhood absence seizures. Functions by suppressing paroxysmal spike-and-wave patterns associated with lapses of consciousness in absence seizures. Dexpanthenol An alcoholic analogue of D-pantothenic acid that is used as a supplement or application to support a healthy epithelium and is also used to prevent vitamin deficiency in patients receiving total parenteral nutrition (TPN). Panthenol An ingredient used in skin, hair care, and nutritional products but is not an approved medication. Ruboxistaurin Ruboxistaurin has been investigated for the basic science of Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus. LY-2090314 Ly2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. CC-220 CC-220 has been used in trials studying the treatment of Systemic Lupus Erythematosus. Succinimide Not Annotated Hopantenic acid Hopantenic acid (Pantogam) is a central nervous system depressant. Hopantenic acid has a unique spectrum of pharmacological effects (nootropic, anticonvulsant, mild activating) in the absence of addiction, hyperstimulation or withdrawal... CEP-9722 CEP-9722 is under investigation in clinical trial NCT01345357 (Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma). Albuvirtide Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).
- Drugs & Drug Targets